February 17, 2015.
With a population of 420 million generating $4660 billion in GDP, Eastern Europe is swiftly gaining momentum as a key area for private and public investment in healthcare and health services, according to a new Frost & Sullivan Insights report.
Eastern Europe Healthcare Outlook 2014 points to “booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS”, shedding light on the changing healthcare dynamics in the region. With the number of hospitals reaching nearly 15.000 units, healthcare spending has been growing from $260 billion of 2010 to an additional 13 per cent in 2013. The percentage of private healthcare spending has also seen growth of an additional 6 per cent from 44 per cent of 2010.
To view an infographic on this study, click here: http://corpcom.frost.com/forms/EU_PR_AZanchi_9AB9_13Feb15
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.